Statements Of Changes In Redeemable Convertible Preferred Stock And Stockholders' Equity - USD ($) |
Total |
Cumulative effect of adoption of accounting standard |
Series A Redeemable Convertible Preferred Stock |
Series A-2 Redeemable Convertible Preferred Stock |
Series A-3 Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-in Capital |
Additional Paid-in Capital
Cumulative effect of adoption of accounting standard
|
Accumulated Deficit |
Accumulated Deficit
Cumulative effect of adoption of accounting standard
|
Accumulated Other Comprehensive Income/ (Loss) |
---|---|---|---|---|---|---|---|---|---|---|---|
Balance (in shares) at Dec. 31, 2020 | 121,735,303 | 22,047,361 | 31,209,734 | 1,256,609 | |||||||
Balance at Dec. 31, 2020 | $ (69,374,941) | $ (1,537,274) | $ 35,047,435 | $ 7,685,865 | $ 10,887,449 | $ 126 | $ 8,206,938 | $ (2,277,332) | $ (77,582,005) | $ 740,058 | $ 0 |
Issuance of common stock (in shares) | 7,441,650 | ||||||||||
Issuance of common stock | 114,551,315 | $ 744 | 114,550,571 | ||||||||
Exercise of stock options (in shares) | 197,041 | ||||||||||
Exercise of stock options | 661,657 | $ 20 | 661,637 | ||||||||
Stock-based compensation | 4,309,356 | 4,309,356 | |||||||||
Issuance of Series A redeemable preferred stock upon exercise of warrants (in shares) | 145,000 | ||||||||||
Issuance of Series A redeemable preferred stock upon exercise of warrants | 0 | $ 1,450 | |||||||||
Conversion of preferred stock into common stock, Temporary equity (in shares) | (121,880,303) | (22,047,361) | (31,209,734) | ||||||||
Conversion of preferred stock into common stock | $ (35,048,885) | $ (7,685,865) | $ (10,887,449) | ||||||||
Conversion of preferred stock into common stock (in shares) | 10,144,041 | ||||||||||
Conversion of preferred stock into common stock | 53,622,199 | $ 1,014 | 53,621,185 | ||||||||
Conversion of convertible debt into common stock (in shares) | 3,669,010 | ||||||||||
Conversion of convertible debt into common stock | 30,252,056 | $ 367 | 30,251,689 | ||||||||
Exercise of warrants (in shares) | 2,896 | ||||||||||
Change in unrealized loss on marketable available-for-sale securities | 702 | 702 | |||||||||
Net loss | (35,375,910) | (35,375,910) | |||||||||
Balance (in shares) at Sep. 30, 2021 | 0 | 0 | 0 | 22,711,247 | |||||||
Balance at Sep. 30, 2021 | 97,109,160 | $ 0 | $ 0 | $ 0 | $ 2,271 | 209,324,044 | (112,217,857) | 702 | |||
Balance (in shares) at Jun. 30, 2021 | 22,628,007 | ||||||||||
Balance at Jun. 30, 2021 | 109,909,420 | $ 2,263 | 207,480,819 | (97,570,745) | (2,917) | ||||||
Exercise of stock options (in shares) | 83,240 | ||||||||||
Exercise of stock options | 214,802 | $ 8 | 214,794 | ||||||||
Stock-based compensation | 1,628,431 | 1,628,431 | |||||||||
Change in unrealized loss on marketable available-for-sale securities | 3,619 | 3,619 | |||||||||
Net loss | (14,647,112) | (14,647,112) | |||||||||
Balance (in shares) at Sep. 30, 2021 | 0 | 0 | 0 | 22,711,247 | |||||||
Balance at Sep. 30, 2021 | 97,109,160 | $ 0 | $ 0 | $ 0 | $ 2,271 | 209,324,044 | (112,217,857) | 702 | |||
Balance (in shares) at Dec. 31, 2021 | 0 | 0 | 0 | 22,828,904 | |||||||
Balance at Dec. 31, 2021 | 83,760,667 | $ 0 | $ 0 | $ 0 | $ 2,283 | 211,498,827 | $ (2,300,000) | (127,743,455) | $ 700,000 | 3,012 | |
Issuance of common stock (in shares) | 3,184,900 | ||||||||||
Issuance of common stock | $ 5,145,409 | $ 319 | 5,145,090 | ||||||||
Exercise of stock options (in shares) | 362,886 | 12,890 | |||||||||
Exercise of stock options | $ 33,255 | $ 1 | 33,254 | ||||||||
Stock-based compensation | 4,392,388 | 4,392,388 | |||||||||
Cashless exercise of options for common stock (in shares) | 51,757 | ||||||||||
Cashless exercise of options for common stock | 0 | $ 5 | (5) | ||||||||
Change in unrealized loss on marketable available-for-sale securities | (3,012) | (3,012) | |||||||||
Net loss | (45,613,174) | (45,613,174) | |||||||||
Balance (in shares) at Sep. 30, 2022 | 0 | 0 | 0 | 26,078,451 | |||||||
Balance at Sep. 30, 2022 | 47,715,533 | $ 0 | $ 0 | $ 0 | $ 2,608 | 221,069,554 | (173,356,629) | 0 | |||
Balance (in shares) at Jun. 30, 2022 | 22,893,551 | ||||||||||
Balance at Jun. 30, 2022 | 55,852,681 | $ 2,289 | 214,486,976 | (158,627,249) | (9,335) | ||||||
Issuance of common stock (in shares) | 3,184,900 | ||||||||||
Issuance of common stock | 5,145,409 | $ 319 | 5,145,090 | ||||||||
Stock-based compensation | 1,437,488 | 1,437,488 | |||||||||
Change in unrealized loss on marketable available-for-sale securities | 9,335 | 9,335 | |||||||||
Net loss | (14,729,380) | (14,729,380) | |||||||||
Balance (in shares) at Sep. 30, 2022 | 0 | 0 | 0 | 26,078,451 | |||||||
Balance at Sep. 30, 2022 | $ 47,715,533 | $ 0 | $ 0 | $ 0 | $ 2,608 | $ 221,069,554 | $ (173,356,629) | $ 0 |